Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Non-Current Deffered Revenue: 2017-2021

Historic Non-Current Deffered Revenue for Solid Biosciences (SLDB) over the last 1 years, with Sep 2021 value amounting to $2.3 million.

  • Solid Biosciences' Non-Current Deffered Revenue was N/A to $2.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $10.4 million for FY2020, which is N/A change from last year.
  • Per Solid Biosciences' latest filing, its Non-Current Deffered Revenue stood at $2.3 million for Q3 2021, which was down 47.52% from $4.3 million recorded in Q2 2021.
  • Solid Biosciences' Non-Current Deffered Revenue's 5-year high stood at $10.4 million during Q4 2020, with a 5-year trough of $2.3 million in Q3 2021.
  • In the last 2 years, Solid Biosciences' Non-Current Deffered Revenue had a median value of $5.7 million in 2021 and averaged $6.0 million.